aluates Reports

$ 0.0

Automative

Global Pharmaceuticals and Biotechnology R & D Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-15Z7791

Global Pharmaceuticals and Biotechnology R D Market Insights Forecast to 2028

BUY CHAPTERS

Global Pharmaceuticals and Biotechnology R & D Market Research Report 2024

Code: QYRE-Auto-15Z7791

Report

March 2024

Pages:104

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Pharmaceuticals and Biotechnology R & D Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmaceuticals and Biotechnology R & D Market

The global Pharmaceuticals and Biotechnology R & D market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmaceuticals and Biotechnology R & D, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceuticals and Biotechnology R & D.

Report Scope

The Pharmaceuticals and Biotechnology R & D market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceuticals and Biotechnology R & D market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceuticals and Biotechnology R & D companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmaceuticals and Biotechnology R & D Market Report

Report Metric	Details
Report Name	Pharmaceuticals and Biotechnology R & D Market
CAGR	5%
Segment by Type	Drug Medical Equipment Vaccine Others
Segment by Application	Hospital Clinic Homecare Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ROCHE, JOHNSON & JOHNSON, MERCK, NOVARTIS, PFIZER, SANOFI, BAYER, BRISTOL-MYERS SQUIBB, ASTRAZENECA, GLAXOSMITHKLINE, ABBVIE, ELI LILLY, BOEHRINGER SOHN, AMGEN, GILEAD SCIENCES, TAKEDA PHARMACEUTICAL, NOVO NORDISK, BIOGEN, ABBOTT, ASTELLAS PHARMA, TEVA PHARMACEUTICAL INDUSTRIES
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceuticals and Biotechnology R & D companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceuticals and Biotechnology R & D Market report?

Ans: The main players in the Pharmaceuticals and Biotechnology R & D Market are ROCHE, JOHNSON & JOHNSON, MERCK, NOVARTIS, PFIZER, SANOFI, BAYER, BRISTOL-MYERS SQUIBB, ASTRAZENECA, GLAXOSMITHKLINE, ABBVIE, ELI LILLY, BOEHRINGER SOHN, AMGEN, GILEAD SCIENCES, TAKEDA PHARMACEUTICAL, NOVO NORDISK, BIOGEN, ABBOTT, ASTELLAS PHARMA, TEVA PHARMACEUTICAL INDUSTRIES

What are the Application segmentation covered in the Pharmaceuticals and Biotechnology R & D Market report?

Ans: The Applications covered in the Pharmaceuticals and Biotechnology R & D Market report are Hospital, Clinic, Homecare, Others

What are the Type segmentation covered in the Pharmaceuticals and Biotechnology R & D Market report?

Ans: The Types covered in the Pharmaceuticals and Biotechnology R & D Market report are Drug, Medical Equipment, Vaccine, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Drug

1.2.3 Medical Equipment

1.2.4 Vaccine

1.2.5 Others

1.3 Market by Application

1.3.1 Global Pharmaceuticals and Biotechnology R & D Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Homecare

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceuticals and Biotechnology R & D Market Perspective (2019-2030)

2.2 Pharmaceuticals and Biotechnology R & D Growth Trends by Region

2.2.1 Global Pharmaceuticals and Biotechnology R & D Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Pharmaceuticals and Biotechnology R & D Historic Market Size by Region (2019-2024)

2.2.3 Pharmaceuticals and Biotechnology R & D Forecasted Market Size by Region (2025-2030)

2.3 Pharmaceuticals and Biotechnology R & D Market Dynamics

2.3.1 Pharmaceuticals and Biotechnology R & D Industry Trends

2.3.2 Pharmaceuticals and Biotechnology R & D Market Drivers

2.3.3 Pharmaceuticals and Biotechnology R & D Market Challenges

2.3.4 Pharmaceuticals and Biotechnology R & D Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmaceuticals and Biotechnology R & D Players by Revenue

3.1.1 Global Top Pharmaceuticals and Biotechnology R & D Players by Revenue (2019-2024)

3.1.2 Global Pharmaceuticals and Biotechnology R & D Revenue Market Share by Players (2019-2024)

3.2 Global Pharmaceuticals and Biotechnology R & D Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pharmaceuticals and Biotechnology R & D Revenue

3.4 Global Pharmaceuticals and Biotechnology R & D Market Concentration Ratio

3.4.1 Global Pharmaceuticals and Biotechnology R & D Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceuticals and Biotechnology R & D Revenue in 2023

3.5 Pharmaceuticals and Biotechnology R & D Key Players Head office and Area Served

3.6 Key Players Pharmaceuticals and Biotechnology R & D Product Solution and Service

3.7 Date of Enter into Pharmaceuticals and Biotechnology R & D Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceuticals and Biotechnology R & D Breakdown Data by Type

4.1 Global Pharmaceuticals and Biotechnology R & D Historic Market Size by Type (2019-2024)

4.2 Global Pharmaceuticals and Biotechnology R & D Forecasted Market Size by Type (2025-2030)

5 Pharmaceuticals and Biotechnology R & D Breakdown Data by Application

5.1 Global Pharmaceuticals and Biotechnology R & D Historic Market Size by Application (2019-2024)

5.2 Global Pharmaceuticals and Biotechnology R & D Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Pharmaceuticals and Biotechnology R & D Market Size (2019-2030)

6.2 North America Pharmaceuticals and Biotechnology R & D Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Pharmaceuticals and Biotechnology R & D Market Size by Country (2019-2024)

6.4 North America Pharmaceuticals and Biotechnology R & D Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmaceuticals and Biotechnology R & D Market Size (2019-2030)

7.2 Europe Pharmaceuticals and Biotechnology R & D Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Pharmaceuticals and Biotechnology R & D Market Size by Country (2019-2024)

7.4 Europe Pharmaceuticals and Biotechnology R & D Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size (2019-2030)

8.2 Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size by Region (2019-2024)

8.4 Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharmaceuticals and Biotechnology R & D Market Size (2019-2030)

9.2 Latin America Pharmaceuticals and Biotechnology R & D Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Pharmaceuticals and Biotechnology R & D Market Size by Country (2019-2024)

9.4 Latin America Pharmaceuticals and Biotechnology R & D Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size (2019-2030)

10.2 Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size by Country (2019-2024)

10.4 Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ROCHE

11.1.1 ROCHE Company Detail

11.1.2 ROCHE Business Overview

11.1.3 ROCHE Pharmaceuticals and Biotechnology R & D Introduction

11.1.4 ROCHE Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.1.5 ROCHE Recent Development

11.2 JOHNSON & JOHNSON

11.2.1 JOHNSON & JOHNSON Company Detail

11.2.2 JOHNSON & JOHNSON Business Overview

11.2.3 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Introduction

11.2.4 JOHNSON & JOHNSON Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.2.5 JOHNSON & JOHNSON Recent Development

11.3 MERCK

11.3.1 MERCK Company Detail

11.3.2 MERCK Business Overview

11.3.3 MERCK Pharmaceuticals and Biotechnology R & D Introduction

11.3.4 MERCK Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.3.5 MERCK Recent Development

11.4 NOVARTIS

11.4.1 NOVARTIS Company Detail

11.4.2 NOVARTIS Business Overview

11.4.3 NOVARTIS Pharmaceuticals and Biotechnology R & D Introduction

11.4.4 NOVARTIS Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.4.5 NOVARTIS Recent Development

11.5 PFIZER

11.5.1 PFIZER Company Detail

11.5.2 PFIZER Business Overview

11.5.3 PFIZER Pharmaceuticals and Biotechnology R & D Introduction

11.5.4 PFIZER Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.5.5 PFIZER Recent Development

11.6 SANOFI

11.6.1 SANOFI Company Detail

11.6.2 SANOFI Business Overview

11.6.3 SANOFI Pharmaceuticals and Biotechnology R & D Introduction

11.6.4 SANOFI Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.6.5 SANOFI Recent Development

11.7 BAYER

11.7.1 BAYER Company Detail

11.7.2 BAYER Business Overview

11.7.3 BAYER Pharmaceuticals and Biotechnology R & D Introduction

11.7.4 BAYER Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.7.5 BAYER Recent Development

11.8 BRISTOL-MYERS SQUIBB

11.8.1 BRISTOL-MYERS SQUIBB Company Detail

11.8.2 BRISTOL-MYERS SQUIBB Business Overview

11.8.3 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Introduction

11.8.4 BRISTOL-MYERS SQUIBB Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.8.5 BRISTOL-MYERS SQUIBB Recent Development

11.9 ASTRAZENECA

11.9.1 ASTRAZENECA Company Detail

11.9.2 ASTRAZENECA Business Overview

11.9.3 ASTRAZENECA Pharmaceuticals and Biotechnology R & D Introduction

11.9.4 ASTRAZENECA Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.9.5 ASTRAZENECA Recent Development

11.10 GLAXOSMITHKLINE

11.10.1 GLAXOSMITHKLINE Company Detail

11.10.2 GLAXOSMITHKLINE Business Overview

11.10.3 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Introduction

11.10.4 GLAXOSMITHKLINE Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.10.5 GLAXOSMITHKLINE Recent Development

11.11 ABBVIE

11.11.1 ABBVIE Company Detail

11.11.2 ABBVIE Business Overview

11.11.3 ABBVIE Pharmaceuticals and Biotechnology R & D Introduction

11.11.4 ABBVIE Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.11.5 ABBVIE Recent Development

11.12 ELI LILLY

11.12.1 ELI LILLY Company Detail

11.12.2 ELI LILLY Business Overview

11.12.3 ELI LILLY Pharmaceuticals and Biotechnology R & D Introduction

11.12.4 ELI LILLY Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.12.5 ELI LILLY Recent Development

11.13 BOEHRINGER SOHN

11.13.1 BOEHRINGER SOHN Company Detail

11.13.2 BOEHRINGER SOHN Business Overview

11.13.3 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Introduction

11.13.4 BOEHRINGER SOHN Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.13.5 BOEHRINGER SOHN Recent Development

11.14 AMGEN

11.14.1 AMGEN Company Detail

11.14.2 AMGEN Business Overview

11.14.3 AMGEN Pharmaceuticals and Biotechnology R & D Introduction

11.14.4 AMGEN Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.14.5 AMGEN Recent Development

11.15 GILEAD SCIENCES

11.15.1 GILEAD SCIENCES Company Detail

11.15.2 GILEAD SCIENCES Business Overview

11.15.3 GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Introduction

11.15.4 GILEAD SCIENCES Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.15.5 GILEAD SCIENCES Recent Development

11.16 TAKEDA PHARMACEUTICAL

11.16.1 TAKEDA PHARMACEUTICAL Company Detail

11.16.2 TAKEDA PHARMACEUTICAL Business Overview

11.16.3 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Introduction

11.16.4 TAKEDA PHARMACEUTICAL Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.16.5 TAKEDA PHARMACEUTICAL Recent Development

11.17 NOVO NORDISK

11.17.1 NOVO NORDISK Company Detail

11.17.2 NOVO NORDISK Business Overview

11.17.3 NOVO NORDISK Pharmaceuticals and Biotechnology R & D Introduction

11.17.4 NOVO NORDISK Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.17.5 NOVO NORDISK Recent Development

11.18 BIOGEN

11.18.1 BIOGEN Company Detail

11.18.2 BIOGEN Business Overview

11.18.3 BIOGEN Pharmaceuticals and Biotechnology R & D Introduction

11.18.4 BIOGEN Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.18.5 BIOGEN Recent Development

11.19 ABBOTT

11.19.1 ABBOTT Company Detail

11.19.2 ABBOTT Business Overview

11.19.3 ABBOTT Pharmaceuticals and Biotechnology R & D Introduction

11.19.4 ABBOTT Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.19.5 ABBOTT Recent Development

11.20 ASTELLAS PHARMA

11.20.1 ASTELLAS PHARMA Company Detail

11.20.2 ASTELLAS PHARMA Business Overview

11.20.3 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Introduction

11.20.4 ASTELLAS PHARMA Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.20.5 ASTELLAS PHARMA Recent Development

11.21 TEVA PHARMACEUTICAL INDUSTRIES

11.21.1 TEVA PHARMACEUTICAL INDUSTRIES Company Detail

11.21.2 TEVA PHARMACEUTICAL INDUSTRIES Business Overview

11.21.3 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Introduction

11.21.4 TEVA PHARMACEUTICAL INDUSTRIES Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

11.21.5 TEVA PHARMACEUTICAL INDUSTRIES Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Drug

Table 3. Key Players of Medical Equipment

Table 4. Key Players of Vaccine

Table 5. Key Players of Others

Table 6. Global Pharmaceuticals and Biotechnology R & D Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Pharmaceuticals and Biotechnology R & D Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Pharmaceuticals and Biotechnology R & D Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Pharmaceuticals and Biotechnology R & D Market Share by Region (2019-2024)

Table 10. Global Pharmaceuticals and Biotechnology R & D Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Pharmaceuticals and Biotechnology R & D Market Share by Region (2025-2030)

Table 12. Pharmaceuticals and Biotechnology R & D Market Trends

Table 13. Pharmaceuticals and Biotechnology R & D Market Drivers

Table 14. Pharmaceuticals and Biotechnology R & D Market Challenges

Table 15. Pharmaceuticals and Biotechnology R & D Market Restraints

Table 16. Global Pharmaceuticals and Biotechnology R & D Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Pharmaceuticals and Biotechnology R & D Market Share by Players (2019-2024)

Table 18. Global Top Pharmaceuticals and Biotechnology R & D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceuticals and Biotechnology R & D as of 2023)

Table 19. Ranking of Global Top Pharmaceuticals and Biotechnology R & D Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Pharmaceuticals and Biotechnology R & D Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Pharmaceuticals and Biotechnology R & D Product Solution and Service

Table 23. Date of Enter into Pharmaceuticals and Biotechnology R & D Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Pharmaceuticals and Biotechnology R & D Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Pharmaceuticals and Biotechnology R & D Revenue Market Share by Type (2019-2024)

Table 27. Global Pharmaceuticals and Biotechnology R & D Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Pharmaceuticals and Biotechnology R & D Revenue Market Share by Type (2025-2030)

Table 29. Global Pharmaceuticals and Biotechnology R & D Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Pharmaceuticals and Biotechnology R & D Revenue Market Share by Application (2019-2024)

Table 31. Global Pharmaceuticals and Biotechnology R & D Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Pharmaceuticals and Biotechnology R & D Revenue Market Share by Application (2025-2030)

Table 33. North America Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Pharmaceuticals and Biotechnology R & D Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Pharmaceuticals and Biotechnology R & D Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Pharmaceuticals and Biotechnology R & D Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Pharmaceuticals and Biotechnology R & D Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Pharmaceuticals and Biotechnology R & D Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Pharmaceuticals and Biotechnology R & D Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size by Country (2025-2030) & (US$ Million)

Table 48. ROCHE Company Detail

Table 49. ROCHE Business Overview

Table 50. ROCHE Pharmaceuticals and Biotechnology R & D Product

Table 51. ROCHE Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 52. ROCHE Recent Development

Table 53. JOHNSON & JOHNSON Company Detail

Table 54. JOHNSON & JOHNSON Business Overview

Table 55. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Product

Table 56. JOHNSON & JOHNSON Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 57. JOHNSON & JOHNSON Recent Development

Table 58. MERCK Company Detail

Table 59. MERCK Business Overview

Table 60. MERCK Pharmaceuticals and Biotechnology R & D Product

Table 61. MERCK Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 62. MERCK Recent Development

Table 63. NOVARTIS Company Detail

Table 64. NOVARTIS Business Overview

Table 65. NOVARTIS Pharmaceuticals and Biotechnology R & D Product

Table 66. NOVARTIS Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 67. NOVARTIS Recent Development

Table 68. PFIZER Company Detail

Table 69. PFIZER Business Overview

Table 70. PFIZER Pharmaceuticals and Biotechnology R & D Product

Table 71. PFIZER Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 72. PFIZER Recent Development

Table 73. SANOFI Company Detail

Table 74. SANOFI Business Overview

Table 75. SANOFI Pharmaceuticals and Biotechnology R & D Product

Table 76. SANOFI Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 77. SANOFI Recent Development

Table 78. BAYER Company Detail

Table 79. BAYER Business Overview

Table 80. BAYER Pharmaceuticals and Biotechnology R & D Product

Table 81. BAYER Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 82. BAYER Recent Development

Table 83. BRISTOL-MYERS SQUIBB Company Detail

Table 84. BRISTOL-MYERS SQUIBB Business Overview

Table 85. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Product

Table 86. BRISTOL-MYERS SQUIBB Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 87. BRISTOL-MYERS SQUIBB Recent Development

Table 88. ASTRAZENECA Company Detail

Table 89. ASTRAZENECA Business Overview

Table 90. ASTRAZENECA Pharmaceuticals and Biotechnology R & D Product

Table 91. ASTRAZENECA Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 92. ASTRAZENECA Recent Development

Table 93. GLAXOSMITHKLINE Company Detail

Table 94. GLAXOSMITHKLINE Business Overview

Table 95. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Product

Table 96. GLAXOSMITHKLINE Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 97. GLAXOSMITHKLINE Recent Development

Table 98. ABBVIE Company Detail

Table 99. ABBVIE Business Overview

Table 100. ABBVIE Pharmaceuticals and Biotechnology R & D Product

Table 101. ABBVIE Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 102. ABBVIE Recent Development

Table 103. ELI LILLY Company Detail

Table 104. ELI LILLY Business Overview

Table 105. ELI LILLY Pharmaceuticals and Biotechnology R & D Product

Table 106. ELI LILLY Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 107. ELI LILLY Recent Development

Table 108. BOEHRINGER SOHN Company Detail

Table 109. BOEHRINGER SOHN Business Overview

Table 110. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Product

Table 111. BOEHRINGER SOHN Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 112. BOEHRINGER SOHN Recent Development

Table 113. AMGEN Company Detail

Table 114. AMGEN Business Overview

Table 115. AMGEN Pharmaceuticals and Biotechnology R & D Product

Table 116. AMGEN Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 117. AMGEN Recent Development

Table 118. GILEAD SCIENCES Company Detail

Table 119. GILEAD SCIENCES Business Overview

Table 120. GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Product

Table 121. GILEAD SCIENCES Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 122. GILEAD SCIENCES Recent Development

Table 123. TAKEDA PHARMACEUTICAL Company Detail

Table 124. TAKEDA PHARMACEUTICAL Business Overview

Table 125. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Product

Table 126. TAKEDA PHARMACEUTICAL Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 127. TAKEDA PHARMACEUTICAL Recent Development

Table 128. NOVO NORDISK Company Detail

Table 129. NOVO NORDISK Business Overview

Table 130. NOVO NORDISK Pharmaceuticals and Biotechnology R & D Product

Table 131. NOVO NORDISK Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 132. NOVO NORDISK Recent Development

Table 133. BIOGEN Company Detail

Table 134. BIOGEN Business Overview

Table 135. BIOGEN Pharmaceuticals and Biotechnology R & D Product

Table 136. BIOGEN Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 137. BIOGEN Recent Development

Table 138. ABBOTT Company Detail

Table 139. ABBOTT Business Overview

Table 140. ABBOTT Pharmaceuticals and Biotechnology R & D Product

Table 141. ABBOTT Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 142. ABBOTT Recent Development

Table 143. ASTELLAS PHARMA Company Detail

Table 144. ASTELLAS PHARMA Business Overview

Table 145. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Product

Table 146. ASTELLAS PHARMA Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 147. ASTELLAS PHARMA Recent Development

Table 148. TEVA PHARMACEUTICAL INDUSTRIES Company Detail

Table 149. TEVA PHARMACEUTICAL INDUSTRIES Business Overview

Table 150. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Product

Table 151. TEVA PHARMACEUTICAL INDUSTRIES Revenue in Pharmaceuticals and Biotechnology R & D Business (2019-2024) & (US$ Million)

Table 152. TEVA PHARMACEUTICAL INDUSTRIES Recent Development

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmaceuticals and Biotechnology R & D Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Pharmaceuticals and Biotechnology R & D Market Share by Type: 2023 VS 2030

Figure 3. Drug Features

Figure 4. Medical Equipment Features

Figure 5. Vaccine Features

Figure 6. Others Features

Figure 7. Global Pharmaceuticals and Biotechnology R & D Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Pharmaceuticals and Biotechnology R & D Market Share by Application: 2023 VS 2030

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Homecare Case Studies

Figure 12. Others Case Studies

Figure 13. Pharmaceuticals and Biotechnology R & D Report Years Considered

Figure 14. Global Pharmaceuticals and Biotechnology R & D Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Pharmaceuticals and Biotechnology R & D Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Pharmaceuticals and Biotechnology R & D Market Share by Region: 2023 VS 2030

Figure 17. Global Pharmaceuticals and Biotechnology R & D Market Share by Players in 2023

Figure 18. Global Top Pharmaceuticals and Biotechnology R & D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceuticals and Biotechnology R & D as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Pharmaceuticals and Biotechnology R & D Revenue in 2023

Figure 20. North America Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Pharmaceuticals and Biotechnology R & D Market Share by Country (2019-2030)

Figure 22. United States Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Pharmaceuticals and Biotechnology R & D Market Share by Country (2019-2030)

Figure 26. Germany Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Pharmaceuticals and Biotechnology R & D Market Share by Region (2019-2030)

Figure 34. China Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Pharmaceuticals and Biotechnology R & D Market Share by Country (2019-2030)

Figure 42. Mexico Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Pharmaceuticals and Biotechnology R & D Market Share by Country (2019-2030)

Figure 46. Turkey Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Pharmaceuticals and Biotechnology R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. ROCHE Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 49. JOHNSON & JOHNSON Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 50. MERCK Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 51. NOVARTIS Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 52. PFIZER Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 53. SANOFI Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 54. BAYER Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 55. BRISTOL-MYERS SQUIBB Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 56. ASTRAZENECA Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 57. GLAXOSMITHKLINE Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 58. ABBVIE Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 59. ELI LILLY Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 60. BOEHRINGER SOHN Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 61. AMGEN Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 62. GILEAD SCIENCES Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 63. TAKEDA PHARMACEUTICAL Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 64. NOVO NORDISK Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 65. BIOGEN Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 66. ABBOTT Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 67. ASTELLAS PHARMA Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 68. TEVA PHARMACEUTICAL INDUSTRIES Revenue Growth Rate in Pharmaceuticals and Biotechnology R & D Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-31X2542

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

ELISA Technologies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-6C4296

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Blow-Fill-Seal (BFS) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-22N3952

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Membrane Technology in Pharma, Biopharma, And Life Science - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5A6999

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Pharmaceuticals and Biotechnology R & D Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-15Z7791

Global Pharmaceuticals and Biotechnology R & D Market Research Report 2024

FEATURED COMPANIES

Pharmaceuticals and Biotechnology R & D Market Size

Pharmaceuticals and Biotechnology R & D Market

Report Scope

Scope of Pharmaceuticals and Biotechnology R & D Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Pharmaceuticals and Biotechnology R & D Market report?

What are the Application segmentation covered in the Pharmaceuticals and Biotechnology R & D Market report?

What are the Type segmentation covered in the Pharmaceuticals and Biotechnology R & D Market report?

FEATURED COMPANIES

RELATED REPORTS